INTRAVESICAL INSTILLATION BCG IN TREATMENT OF SUPERFICIAL TUMORS CLINIC OF UROLOGY MILITARY MEDICAL ACADEMY ŁÓD¬ Article published in Urologia Polska 1995/48/3.
authors
-
Piotr Kaczmarek, Eugeniusz Mięko¶, Jan Kaczmarek
- Z Kliniki Urologii Instytutu Chirurgii WAM w Łodzi
Kierownik Kliniki: prof. dr hab. med. E. Mięko¶
summary
- The authors present the results of two year obserwation of 56 patients with superficial bladder
- tumors. After electrosection of a tumor, 36 patiens (64,28%) were given installations BCG, but 20
- 35,71%
- ment). During the further observation of the patients, it come out that in the grup I BCG there was no
- recurrent tumor with 21 (58,47%) patients Comparing to only 4 (20%) patients in the grup II. The
- results were statistically proved.
references
- 1. Bettex Ganlland M., Studer U.E., Walz A.: Neutropilactiwating peptide-1 (interleukin-8 detec-
- tion) in human urine during acute bladder inflammation caused by transurethral resection of superfi-
- cial cancer and bacillus Calmette - Guerin administration. Eur.Urol., 1991, 19(2), 171 - 5. ? 2.
- BohleA., GardesJ., UlmerA.J.; Effects of local BCG therapy in patients with bladder carcinoma on
- immunocom petent cells of the bladder wall. J. Urol., 1990 Jul, 144(1), 53-8. ? 3. Chopin D.,
- Hoznek A., Colombel M.: Results of treatment of superficial vesical tumors by transurethral resection
- alone and transurethral resection followed by on intra- vesical instillation of Calmette Guerin bacil-
- lus. Ann. Urol. Paris, 1991, 24(5), 435 - 40. ? 4. Debruyne F. M. J., Witjas J. A.: The treatment of
- supperficial bladder tumors and carcinoma in situ with intravesical instillations of Bacillus Calmet-
- te - Guerin. Interface, 1990. ? 5. de Kernion J.B.: Intravesical therapy with BCG. Immuno therapy
- of Urological. Tumours Society Internationale D' Urologie, 1990, 113 - 117. ? 6. Jakse G:. BCG for
- carcinoma in situ. Eur. Urol., 1992, 21 ( supp 2 ), 30 - 34. ? 7. Lamm D.L.: Optimal BCG treatment
- of superficial bladder cancer as defined by American Trials. Eur. Urol., 1992, 21, 12 - 16. 8. Lamm
- D.L.: Open questions on mechanismus BCG. Eur. Urol., 1992, 21, 28 - 29. ? 9. Leong A.S., Wanna-
- krairot P., Jose J:. Bacillus Calmette- Guerin treated superficial bladder cancer, corelation of mor-
- phology with immunophenotyping. J. Pathol., 1990, Sep., 162 (1), 35 - 41. ? 10. Mięko¶ E:. Evalu-
- ation of urinary bladder tumor growth with transurethral ultrasonography. 6th Congress of the Euro-
- pean Federatione of Societies ?Euroson- 87", Helsinki 1987, 131. ? 11. Mikkelsen D. J., Ratlif
- T.L.: Mechanisms of action of in- travesical BCG for bladder cancer. Cancer. Treat. Res., 1989, 46,
- 195 - 211. ? 12. Oda H., Sęki N., Nabeshima S:. Comperative clinical trial of UFT medication and
- interavesical BCG in the recurrens of superficial bladder cancer. Study group of UFT and BCG
- adjuyant therapy for bladder cancer. Gan. To. Kagaku. Ryoho., 1990, Oct., 17 (10), 2051-5. ? 13.
- RaliffT.: Role of the immunorespons in BCG for bladder cancer. Eur. Urol., 1992, 21 (supp 2), 17-
- 21. ? 14. Schmidt J.D.: Interavesical BCG for superficial bladder cancer comporison of prymary
- tumour to development of progressive disease elsewhere. Immurnotherapy of urological tumours,
- Society Internationale D'Urologie, 1990, 53-8. ? 15.Yabusaki N., KamatsuH., Tag K.: Intravesical
- instillation of bacillus Calmette - Guerin in the treatment of superficial montenance instillations of
- BCG. Nippon Hinyokika Gakkai Zasshi, 1990, Feb., 82 (2), 290-6. ? 16. Yamamolo T., Haggiwara
- M, Nakazano M:. Intervesical bacillus Calmette - Guerin in the treatment of superficial bladder
- cancer. Prospects randomized study for prophilactic effeet. Nippozi Hinyokika Gakkai Zsshi, 1990,
- Jul., 81 (7), 997-1001. ? 17. Zieliński J:. Onkologia urologiczna, PZWL, 1986.
|